Literature DB >> 35122077

Gradient of Developmental and Injury Response transcriptional states defines functional vulnerabilities underpinning glioblastoma heterogeneity.

Laura M Richards1,2, Owen K N Whitley3,4, Graham MacLeod5, Florence M G Cavalli6, Fiona J Coutinho6, Julia E Jaramillo3,6, Nataliia Svergun6, Mazdak Riverin2, Danielle C Croucher1,2, Michelle Kushida6, Kenny Yu7, Paul Guilhamon6, Naghmeh Rastegar6, Moloud Ahmadi5, Jasmine K Bhatti5, Danielle A Bozek8,9, Naijin Li3,6, Lilian Lee6, Clare Che6, Erika Luis6, Nicole I Park2, Zhiyu Xu2, Troy Ketela2, Richard A Moore10, Marco A Marra10,11, Julian Spears7,12, Michael D Cusimano7,12, Sunit Das6,7,12, Mark Bernstein12,13, Benjamin Haibe-Kains1,2,14,15,16, Mathieu Lupien1,2,14, H Artee Luchman8,9, Samuel Weiss8,9, Stephane Angers5,17, Peter B Dirks18,19,20, Gary D Bader21,22,23, Trevor J Pugh24,25,26.   

Abstract

Glioblastomas harbor diverse cell populations, including rare glioblastoma stem cells (GSCs) that drive tumorigenesis. To characterize functional diversity within this population, we performed single-cell RNA sequencing on >69,000 GSCs cultured from the tumors of 26 patients. We observed a high degree of inter- and intra-GSC transcriptional heterogeneity that could not be fully explained by DNA somatic alterations. Instead, we found that GSCs mapped along a transcriptional gradient spanning two cellular states reminiscent of normal neural development and inflammatory wound response. Genome-wide CRISPR-Cas9 dropout screens independently recapitulated this observation, with each state characterized by unique essential genes. Further single-cell RNA sequencing of >56,000 malignant cells from primary tumors found that the majority organize along an orthogonal astrocyte maturation gradient yet retain expression of founder GSC transcriptional programs. We propose that glioblastomas grow out of a fundamental GSC-based neural wound response transcriptional program, which is a promising target for new therapy development.
© 2021. The Author(s), under exclusive licence to Springer Nature America, Inc. part of Springer Nature.

Entities:  

Mesh:

Year:  2021        PMID: 35122077     DOI: 10.1038/s43018-020-00154-9

Source DB:  PubMed          Journal:  Nat Cancer        ISSN: 2662-1347


  65 in total

1.  The somatic genomic landscape of glioblastoma.

Authors:  Cameron W Brennan; Roel G W Verhaak; Aaron McKenna; Benito Campos; Houtan Noushmehr; Sofie R Salama; Siyuan Zheng; Debyani Chakravarty; J Zachary Sanborn; Samuel H Berman; Rameen Beroukhim; Brady Bernard; Chang-Jiun Wu; Giannicola Genovese; Ilya Shmulevich; Jill Barnholtz-Sloan; Lihua Zou; Rahulsimham Vegesna; Sachet A Shukla; Giovanni Ciriello; W K Yung; Wei Zhang; Carrie Sougnez; Tom Mikkelsen; Kenneth Aldape; Darell D Bigner; Erwin G Van Meir; Michael Prados; Andrew Sloan; Keith L Black; Jennifer Eschbacher; Gaetano Finocchiaro; William Friedman; David W Andrews; Abhijit Guha; Mary Iacocca; Brian P O'Neill; Greg Foltz; Jerome Myers; Daniel J Weisenberger; Robert Penny; Raju Kucherlapati; Charles M Perou; D Neil Hayes; Richard Gibbs; Marco Marra; Gordon B Mills; Eric Lander; Paul Spellman; Richard Wilson; Chris Sander; John Weinstein; Matthew Meyerson; Stacey Gabriel; Peter W Laird; David Haussler; Gad Getz; Lynda Chin
Journal:  Cell       Date:  2013-10-10       Impact factor: 41.582

2.  Single cell-derived clonal analysis of human glioblastoma links functional and genomic heterogeneity.

Authors:  Mona Meyer; Jüri Reimand; Xiaoyang Lan; Renee Head; Xueming Zhu; Michelle Kushida; Jane Bayani; Jessica C Pressey; Anath C Lionel; Ian D Clarke; Michael Cusimano; Jeremy A Squire; Stephen W Scherer; Mark Bernstein; Melanie A Woodin; Gary D Bader; Peter B Dirks
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-05       Impact factor: 11.205

3.  Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment.

Authors:  Qianghu Wang; Baoli Hu; Xin Hu; Hoon Kim; Massimo Squatrito; Lisa Scarpace; Ana C deCarvalho; Sali Lyu; Pengping Li; Yan Li; Floris Barthel; Hee Jin Cho; Yu-Hsi Lin; Nikunj Satani; Emmanuel Martinez-Ledesma; Siyuan Zheng; Edward Chang; Charles-Etienne Gabriel Sauvé; Adriana Olar; Zheng D Lan; Gaetano Finocchiaro; Joanna J Phillips; Mitchel S Berger; Konrad R Gabrusiewicz; Guocan Wang; Eskil Eskilsson; Jian Hu; Tom Mikkelsen; Ronald A DePinho; Florian Muller; Amy B Heimberger; Erik P Sulman; Do-Hyun Nam; Roel G W Verhaak
Journal:  Cancer Cell       Date:  2017-07-10       Impact factor: 31.743

4.  Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma.

Authors:  Anoop P Patel; Itay Tirosh; John J Trombetta; Alex K Shalek; Shawn M Gillespie; Hiroaki Wakimoto; Daniel P Cahill; Brian V Nahed; William T Curry; Robert L Martuza; David N Louis; Orit Rozenblatt-Rosen; Mario L Suvà; Aviv Regev; Bradley E Bernstein
Journal:  Science       Date:  2014-06-12       Impact factor: 47.728

5.  Single-Cell RNA-Seq Analysis of Infiltrating Neoplastic Cells at the Migrating Front of Human Glioblastoma.

Authors:  Spyros Darmanis; Steven A Sloan; Derek Croote; Marco Mignardi; Sophia Chernikova; Peyman Samghababi; Ye Zhang; Norma Neff; Mark Kowarsky; Christine Caneda; Gordon Li; Steven D Chang; Ian David Connolly; Yingmei Li; Ben A Barres; Melanie Hayden Gephart; Stephen R Quake
Journal:  Cell Rep       Date:  2017-10-31       Impact factor: 9.423

6.  Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.

Authors:  Roel G W Verhaak; Katherine A Hoadley; Elizabeth Purdom; Victoria Wang; Yuan Qi; Matthew D Wilkerson; C Ryan Miller; Li Ding; Todd Golub; Jill P Mesirov; Gabriele Alexe; Michael Lawrence; Michael O'Kelly; Pablo Tamayo; Barbara A Weir; Stacey Gabriel; Wendy Winckler; Supriya Gupta; Lakshmi Jakkula; Heidi S Feiler; J Graeme Hodgson; C David James; Jann N Sarkaria; Cameron Brennan; Ari Kahn; Paul T Spellman; Richard K Wilson; Terence P Speed; Joe W Gray; Matthew Meyerson; Gad Getz; Charles M Perou; D Neil Hayes
Journal:  Cancer Cell       Date:  2010-01-19       Impact factor: 31.743

7.  Sox2 promotes malignancy in glioblastoma by regulating plasticity and astrocytic differentiation.

Authors:  Artem D Berezovsky; Laila M Poisson; David Cherba; Craig P Webb; Andrea D Transou; Nancy W Lemke; Xin Hong; Laura A Hasselbach; Susan M Irtenkauf; Tom Mikkelsen; Ana C deCarvalho
Journal:  Neoplasia       Date:  2014-04-13       Impact factor: 5.715

8.  Outer Radial Glia-like Cancer Stem Cells Contribute to Heterogeneity of Glioblastoma.

Authors:  Aparna Bhaduri; Elizabeth Di Lullo; Diane Jung; Sören Müller; Elizabeth Erin Crouch; Carmen Sandoval Espinosa; Tomoko Ozawa; Beatriz Alvarado; Julien Spatazza; Cathryn René Cadwell; Grace Wilkins; Dmitry Velmeshev; Siyuan John Liu; Martina Malatesta; Madeline Gail Andrews; Mohammed Andres Mostajo-Radji; Eric Jinsheng Huang; Tomasz Jan Nowakowski; Daniel Amos Lim; Aaron Diaz; David Ronan Raleigh; Arnold Richard Kriegstein
Journal:  Cell Stem Cell       Date:  2020-01-02       Impact factor: 24.633

Review 9.  Emerging treatment strategies for glioblastoma multiforme.

Authors:  Steven K Carlsson; Shaun P Brothers; Claes Wahlestedt
Journal:  EMBO Mol Med       Date:  2014-11       Impact factor: 12.137

10.  Fate mapping of human glioblastoma reveals an invariant stem cell hierarchy.

Authors:  Xiaoyang Lan; David J Jörg; Florence M G Cavalli; Laura M Richards; Long V Nguyen; Robert J Vanner; Paul Guilhamon; Lilian Lee; Michelle M Kushida; Davide Pellacani; Nicole I Park; Fiona J Coutinho; Heather Whetstone; Hayden J Selvadurai; Clare Che; Betty Luu; Annaick Carles; Michelle Moksa; Naghmeh Rastegar; Renee Head; Sonam Dolma; Panagiotis Prinos; Michael D Cusimano; Sunit Das; Mark Bernstein; Cheryl H Arrowsmith; Andrew J Mungall; Richard A Moore; Yussanne Ma; Marco Gallo; Mathieu Lupien; Trevor J Pugh; Michael D Taylor; Martin Hirst; Connie J Eaves; Benjamin D Simons; Peter B Dirks
Journal:  Nature       Date:  2017-08-30       Impact factor: 49.962

View more
  19 in total

1.  Quiescent human glioblastoma cancer stem cells drive tumor initiation, expansion, and recurrence following chemotherapy.

Authors:  Xuanhua P Xie; Dan R Laks; Daochun Sun; Mungunsarnai Ganbold; Zilai Wang; Alicia M Pedraza; Tejus Bale; Viviane Tabar; Cameron Brennan; Xiuping Zhou; Luis F Parada
Journal:  Dev Cell       Date:  2022-01-10       Impact factor: 12.270

Review 2.  The Oncogenesis of Glial Cells in Diffuse Gliomas and Clinical Opportunities.

Authors:  Qiyuan Zhuang; Hui Yang; Ying Mao
Journal:  Neurosci Bull       Date:  2022-10-13       Impact factor: 5.271

3.  Glioma progression is shaped by genetic evolution and microenvironment interactions.

Authors:  Frederick S Varn; Kevin C Johnson; Jan Martinek; Jason T Huse; MacLean P Nasrallah; Pieter Wesseling; Lee A D Cooper; Tathiane M Malta; Taylor E Wade; Thais S Sabedot; Daniel Brat; Peter V Gould; Adelheid Wöehrer; Kenneth Aldape; Azzam Ismail; Santhosh K Sivajothi; Floris P Barthel; Hoon Kim; Emre Kocakavuk; Nazia Ahmed; Kieron White; Indrani Datta; Hyo-Eun Moon; Steven Pollock; Christine Goldfarb; Ga-Hyun Lee; Luciano Garofano; Kevin J Anderson; Djamel Nehar-Belaid; Jill S Barnholtz-Sloan; Spyridon Bakas; Annette T Byrne; Fulvio D'Angelo; Hui K Gan; Mustafa Khasraw; Simona Migliozzi; D Ryan Ormond; Sun Ha Paek; Erwin G Van Meir; Annemiek M E Walenkamp; Colin Watts; Tobias Weiss; Michael Weller; Karolina Palucka; Lucy F Stead; Laila M Poisson; Houtan Noushmehr; Antonio Iavarone; Roel G W Verhaak
Journal:  Cell       Date:  2022-05-31       Impact factor: 66.850

4.  Metabolic modeling-based drug repurposing in Glioblastoma.

Authors:  Claudio Tomi-Andrino; Alina Pandele; Klaus Winzer; John King; Ruman Rahman; Dong-Hyun Kim
Journal:  Sci Rep       Date:  2022-07-01       Impact factor: 4.996

5.  Glioblastoma: The Current State of Biology and Therapeutic Strategies.

Authors:  Zev A Binder; Donald M O'Rourke
Journal:  Cancer Res       Date:  2022-03-01       Impact factor: 13.312

Review 6.  Disconnecting multicellular networks in brain tumours.

Authors:  Varun Venkataramani; Matthias Schneider; Ulrich Herrlinger; Frank Winkler; Frank Anton Giordano; Thomas Kuner; Wolfgang Wick
Journal:  Nat Rev Cancer       Date:  2022-04-29       Impact factor: 69.800

7.  Surgical resection of glioblastomas induces pleiotrophin-mediated self-renewal of glioblastoma stem cells in recurrent tumors.

Authors:  Arnon Møldrup Knudsen; Bo Halle; Oriane Cédile; Mark Burton; Christina Baun; Helge Thisgaard; Atul Anand; Christopher Hubert; Mads Thomassen; Signe Regner Michaelsen; Birgitte Brinkmann Olsen; Rikke Hedegaard Dahlrot; Rolf Bjerkvig; Justin Durla Lathia; Bjarne Winther Kristensen
Journal:  Neuro Oncol       Date:  2022-07-01       Impact factor: 13.029

8.  CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment.

Authors:  Mathieu Seyfrid; William Thomas Maich; Vaseem Muhammad Shaikh; Nazanin Tatari; Deepak Upreti; Deween Piyasena; Minomi Subapanditha; Neil Savage; Dillon McKenna; Nicholas Mikolajewicz; Hong Han; Chirayu Chokshi; Laura Kuhlmann; Amanda Khoo; Sabra Khalid Salim; Blessing Archibong-Bassey; William Gwynne; Kevin Brown; Nadeem Murtaza; David Bakhshinyan; Parvez Vora; Chitra Venugopal; Jason Moffat; Thomas Kislinger; Sheila Singh
Journal:  J Immunother Cancer       Date:  2022-01       Impact factor: 13.751

9.  Myeloperoxidase exerts anti-tumor activity in glioma after radiotherapy.

Authors:  Muhammad Ali; Giulia Fulci; Mantas Grigalavicius; Benjamin Pulli; Anning Li; Gregory R Wojtkiewicz; Cuihua Wang; Kevin Li-Chun Hsieh; Jenny J Linnoila; Theodossis A Theodossiou; John W Chen
Journal:  Neoplasia       Date:  2022-03-02       Impact factor: 5.715

10.  Tumor Heterogeneity and Molecular Characteristics of Glioblastoma Revealed by Single-Cell RNA-Seq Data Analysis.

Authors:  Dhanusha Yesudhas; S Akila Parvathy Dharshini; Y-H Taguchi; M Michael Gromiha
Journal:  Genes (Basel)       Date:  2022-02-25       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.